Published in Women's Health Weekly, December 9th, 2004
"Because existing surgical and management methods can consistently cure only early-stage ovarian cancer, novel strategies for early detection are required," stated I.I. Decaceres and colleagues. "Silencing of tumor suppressor genes such as p16(INK4a), VHL, and hMLH1 have established promoter hypermethylation as a common mechanism for tumor suppressor inactivation in human cancer and as a promising...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.